Breaking News

BioDuro Opens Shanghai Lab

May 15, 2013

Expands discovery services in Asia Pacific

BioDuro, a PPD Company, has opened a new lab in Shanghai, expanding its drug discovery services in Asia Pacific. The new lab is located in the Waigaoqiao Free Trade Zone, close to local and multinational pharmaceutical and biotechnology companies in Shanghai.
 
The 72,000-sq.-ft. lab, along with 20,000 sq. ft. of office space, offers drug metabolism and pharmacokinetic (DMPK), bioanalytical, chemistry, discovery biology and oncology pharmacology services. Clients also are able to take advantage of PPD’s clinical research services, as well as its library of assays.
 
“As a fully integrated life science research service provider, BioDuro has an experienced team of researchers and scientists with expertise in a wide range of drug discovery services,” said Jasmine Cui, Ph.D., general manager and chief scientific officer of BioDuro. “This new lab will allow us to meet the business needs of our clients more effectively by streamlining the discovery and development process, and continuing to enhance continuity and smooth transitions throughout the stages of development.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.